Target intelligence / Profile preview

Cardiac ventricle

Molecular classification
Other (Anatomical structure, not a molecule/receptor/enzyme/ion channel)
01

Overview

The cardiac ventricle is one of the primary muscular chambers of the heart. There are two ventricles in mammals—one on the left, one on the right—that perform distinct roles: the left ventricle pumps oxygenated blood into the high-pressure systemic circulation, while the right ventricle pumps blood into the lower-pressure pulmonary circuit[2]. The structure and physiological properties of ventricular myocardium have been studied extensively, with significant variation in myoarchitecture (compact, trabeculated, or mixed forms)[1]. Molecularly, cardiac function is coordinated by numerous proteins expressed in ventricular myocytes, including ion channels and contractile apparatus components[2]. However, the ventricle itself is not a protein, receptor, or other conventional drug target but rather a vital organ segment, so drug actions are mediated by molecular targets within ventricular tissue (such as sodium, potassium, and calcium channels; beta-adrenergic receptors; etc.)[2][3]. Developmental processes shaping ventricular formation involve molecular signals like Notch, Neuregulin, Ephrin, BMP10, and transcription factors such as NKX2-5, MEF2C, and GATA4, but these operate within cells of the ventricle, not the ventricle as a molecular entity[3][4]. Ventricles play central roles in cardiovascular disease pathogenesis and progression, with dysfunction manifesting as heart failure, arrhythmia, and remodeling[2][3]. In summary, "cardiac ventricle" is an anatomical structure, not a druggable molecular target, and information mapped to structured target lists should note this as an anatomical term with no canonical molecular target entry.

Other names
Heart ventricleLeft ventricleRight ventricleVentricular chamber
02

Biological functions

Blood pumpingCirculatory system propulsionMaintenance of systemic and pulmonary circulation
03

Disease associations

Cardiovascular disease (role in heart failure, ventricular hypertrophy, congenital cardiac malformations)

Beyond the preview

Go deeper on Cardiac ventricle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac ventricle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call